<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/42186/glaxosmithkline-pharmaceuticals-ltd/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Decoding capital expenditure</title>
			<link>https://www.valueresearchonline.com/stories/46225/decoding-capital-expenditure/</link>
			<pubDate>Thu, 08 Nov 2018 08:00:00 +0530</pubDate>
			<category>Data for Thought</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/46225_in-expansion-mode__w320__h240__.jpg&quot; alt=&quot;Decoding capital expenditure&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Here&#039;s why rising capex can be a good indicator of a company&#039;s growth. Also, find the names of some companies whose capex has risen consistently</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/46225/decoding-capital-expenditure/</guid>
		</item>
		<item>
			<title>The quest for value</title>
			<link>https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</link>
			<pubDate>Tue, 20 Oct 2015 17:56:55 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/29141_29141__w320__h240__.jpg&quot; alt=&quot;The quest for value&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</guid>
		</item>
		<item>
			<title>Pedigree in Lifestyle</title>
			<link>https://www.valueresearchonline.com/stories/20924/pedigree-in-lifestyle/</link>
			<pubDate>Thu, 13 Sep 2012 10:32:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>GSK Pharma’s association with GSK Plc has been fruitful for India’s second-largest pharma company…></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/20924/pedigree-in-lifestyle/</guid>
		</item>
		<item>
			<title>Living The Larger Life</title>
			<link>https://www.valueresearchonline.com/stories/13109/living-the-larger-life/</link>
			<pubDate>Wed, 22 Apr 2009 10:44:00 +0530</pubDate>
			<category>Stock Ideas</category>
			<description>We take a look at mid-caps that have become large-caps, despite plummeting markets></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/13109/living-the-larger-life/</guid>
		</item>
		<item>
			<title>In The Pink Of Health</title>
			<link>https://www.valueresearchonline.com/stories/11343/in-the-pink-of-health/</link>
			<pubDate>Tue, 20 May 2008 14:32:00 +0530</pubDate>
			<category>Fundwire</category>
			<description>Pharma funds have staged a smart recovery after posting negative returns for the past few years></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11343/in-the-pink-of-health/</guid>
		</item>
		<item>
			<title>Nasdaq Tremors Rock Dalal Street</title>
			<link>https://www.valueresearchonline.com/stories/944/nasdaq-tremors-rock-dalal-street/</link>
			<pubDate>Sat, 16 Jun 2001 17:25:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Profit-warning from Nortel, one of the main clients for Infosys and Wipro, pushes the Sensex below 3400></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/944/nasdaq-tremors-rock-dalal-street/</guid>
		</item>
		<item>
			<title>R Sukumar, Fund Manager, KP Pharma Fund, on the potential of Pharma Sector</title>
			<link>https://www.valueresearchonline.com/stories/892/r-sukumar-fund-manager-kp-pharma-fund-on-the-potential-of-pharma-sector/</link>
			<pubDate>Fri, 09 Feb 2001 18:20:00 +0530</pubDate>
			<category>Interview</category>
			<description>&quot;Investors should be prepared to hold any equity fund through economic and stock market cycles &quot;></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/892/r-sukumar-fund-manager-kp-pharma-fund-on-the-potential-of-pharma-sector/</guid>
		</item>
		<item>
			<title>Fund Manager R.Sukumar, on trends in Technology and Pharma Sector.</title>
			<link>https://www.valueresearchonline.com/stories/886/fund-manager-r-sukumar-on-trends-in-technology-and-pharma-sector/</link>
			<pubDate>Mon, 03 Jul 2000 13:52:00 +0530</pubDate>
			<category>Interview</category>
			<description>&quot;We plan to go on with our strategy of picking the best stocks. These stocks we hope will stand up irrespective of a tough market.&quot;></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/886/fund-manager-r-sukumar-on-trends-in-technology-and-pharma-sector/</guid>
		</item>
    </channel>
</rss>
